It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or
consider using other browsers such as Chrome, Firefox or Safari.
Everyone is different, and like any other decision you make when it comes to your health, we know it may be overwhelming to get started. Choose a trial below or use the search to find what you're looking for.
A 12-week, Multicenter, Randomized, Double-blind, Parallel-arm, Placebo-controlled Study to Assess the Efficacy and Safety of CSJ117, When Added to Existing Asthma Therapy in Patients ≥ 18 Years of Age With Severe Uncontrolled Asthma.
ClinicalTrials.gov ID: NCT04410523 | Gender: All | Age(s): 18 Years to 75 Years (Adult, Older Adult) | Drug: CSJ117
A 24-week Multi-center, Double-blind, Placebo Controlled Dose-range Finding Study to Investigate the Efficacy and Safety of Oral QBW251 in COPD Patients on Triple Inhaled Therapy (LABA / LAMA / ICS)
ClinicalTrials.gov ID: NCT04072887 | Gender: All | Age(s): 40 Years and older (Adult, Older Adult) | Drug: QBW251 and Placebo